Showing 1 - 9 of 9
Objectives. The EQ-5D is a preference-based measure of health and is increasingly being used in the evaluation of health technologies. A 'tariff' of values for all 243 EQ-5D health states has been generated using direct valuations on a subset of these states. The tariff is used to express the...
Persistent link: https://www.econbiz.de/10009440527
Persistent link: https://www.econbiz.de/10003839477
Persistent link: https://www.econbiz.de/10009356307
Persistent link: https://www.econbiz.de/10003218401
In this paper, we seek to explore the effects of commuting time on the psychological well-being of men and women in the UK. We use annual data from the British Household Panel Survey in a fixed effects panel framework that includes variables known to determine well-being, as well as factors...
Persistent link: https://www.econbiz.de/10008625812
The time trade-off (TTO) is one of the most widely used health state valuation methods and was recently used to develop a set of values for the EQ-5D descriptive system from 3000 members of the UK general population. However, there is currently very little understanding of precisely what...
Persistent link: https://www.econbiz.de/10008613250
Commuting is an important component of time use for most working people. We explore the effects of commuting time on the psychological health of men and women. We use data from the British Household Panel Survey in a fixed effects framework that includes variables known to determine...
Persistent link: https://www.econbiz.de/10011051279
Expected Utility (EU) theory is the standard economic model of individual preferences under uncertainty. However, observed violations of the axioms of EU have generated interest in the incorporation of a stochastic element into deterministic models of decision-making. Previous empirical...
Persistent link: https://www.econbiz.de/10005628495
The EQ-5D general population valuation set (or 'tariff') is increasingly being used in the evaluation of health care interventions and has been recommended by the National Institute for Clinical Excellence (NICE) for use in cost-utility analyses of health technologies. To be of use to...
Persistent link: https://www.econbiz.de/10005198952